{"id":238422,"date":"2026-09-09T15:14:51","date_gmt":"2026-09-09T09:44:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=238422"},"modified":"2026-09-09T15:14:51","modified_gmt":"2026-09-09T09:44:51","slug":"why-zydus-lifesciences-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/","title":{"rendered":"Zydus Lifesciences (ZYDUSLIFE) Share Price Falls 2.03% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences (ZYDUSLIFE)<\/a>share price fell to Rs 1,126.7 today, down 2.03% from the previous close. Market cap was Rs 1,15,211.69 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Zydus Lifesciences Share Price fell to Rs 1,126.7 on 09 September 2026, down 2.03% for the day. The move took the Large Cap pharmaceutical company\u2019s market capitalisation to Rs 1,15,211.69 crore. Intraday, the stock opened at Rs 1,145.05, touched a high of Rs 1,157.65, and slipped to a low of Rs 1,126.25, leaving it near the session low when this update was prepared.<\/p>\n<p>The verified market data shows a decline of Rs 23.3 from the previous close of Rs 1,150, with turnover of Rs 16.2 crore. The stock is in focus because a large healthcare name saw a meaningful one-day decline. However, the supplied data does not establish any company-specific catalyst for today\u2019s move. What it does show is that the business continues to trade with a P\/E ratio of 25.42, P\/B ratio of 4.25, ROE of 19.69%, and ROCE of 21.39%. That makes the price move worth reading alongside the company\u2019s broader valuation and profitability profile.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Zydus_Lifesciences_ZYDUSLIFE_Share_Price_Today_Price_Action_Analysis\" title=\"Zydus Lifesciences (ZYDUSLIFE) Share Price Today: Price Action Analysis\">Zydus Lifesciences (ZYDUSLIFE) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Zydus_Lifesciences_ZYDUSLIFE_Fundamental_Analysis\" title=\"Zydus Lifesciences (ZYDUSLIFE) Fundamental Analysis\">Zydus Lifesciences (ZYDUSLIFE) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Zydus_Lifesciences\" title=\"Why Investors Are Watching Zydus Lifesciences\">Why Investors Are Watching Zydus Lifesciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#About_Zydus_Lifesciences\" title=\"About Zydus Lifesciences\">About Zydus Lifesciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Track_Zydus_Lifesciences_Share_Price_on_Univest\" title=\"Track Zydus Lifesciences Share Price on Univest\">Track Zydus Lifesciences Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#Why_is_Zydus_Lifesciences_Share_Price_falling_today\" title=\"Why is Zydus Lifesciences Share Price falling today?\">Why is Zydus Lifesciences Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#What_is_Zydus_Lifesciences_Share_Price_Today\" title=\"What is Zydus Lifesciences Share Price Today?\">What is Zydus Lifesciences Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#What_do_valuation_and_profitability_metrics_show\" title=\"What do valuation and profitability metrics show?\">What do valuation and profitability metrics show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-zydus-lifesciences-share-price-fall-today-2026\/#How_does_it_compare_with_industry_benchmarks\" title=\"How does it compare with industry benchmarks?\">How does it compare with industry benchmarks?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_ZYDUSLIFE_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Zydus Lifesciences (ZYDUSLIFE) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,126.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,150<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 23.30 (-2.03%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,145.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,157.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,126.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16.2 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,15,211.69 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Zydus Lifesciences Share Price Today reflects a weak session rather than a brief dip. The stock began below the previous close, briefly moved higher, and then lost ground through the day. The fact that the current price remained only marginally above the low suggests sellers retained control into the later part of the session.<\/p>\n<p>The intraday path is straightforward. After opening at Rs 1,145.05, the stock rose to Rs 1,157.65, showing that there was some early support. That did not hold. The price then declined to Rs 1,126.25, and the last tracked price of Rs 1,126.7 kept it very close to the session bottom. For market participants, that kind of closing position often attracts more attention than a lower close alone because it indicates sustained weakness across the trading day.<\/p>\n<p>Turnover of Rs 16.2 crore also points to active trading interest in a Large Cap counter. The supplied data does not confirm whether the pressure came from company news, broader sector sentiment, or purely market positioning, so it is best to avoid assigning a cause that is not evidenced here.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_ZYDUSLIFE_Fundamental_Analysis\"><\/span><strong>Zydus Lifesciences (ZYDUSLIFE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,15,211.69 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.25x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 45.24<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 270.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.09%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Zydus Lifesciences Fundamental Analysis still points to a large and profitable pharma business despite today\u2019s decline. The stock trades at 25.42 times earnings and 4.25 times book value, while EPS stands at Rs 45.24 and book value per share at Rs 270.31. Dividend yield is 0.09%.<\/p>\n<p>The profitability metrics are notable. ROE of 19.69% indicates strong returns on shareholder equity, and ROCE of 21.39% shows healthy returns on overall capital employed. Those figures matter because price weakness in the short term does not automatically alter the company\u2019s reported return profile. In that sense, today\u2019s move is best read as a market-price event occurring against a still solid profitability backdrop.<\/p>\n<p>For investors reviewing the stock, the mix is clear: a Large Cap company, moderate earnings valuation by industry standards, and return ratios that remain comfortably positive. That combination is one reason the decline may draw attention even without a confirmed trigger in the provided data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.39x to 668.68x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.25x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.12%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.62%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,15,211.69 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 715.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,150.82 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Zydus Lifesciences operates in Healthcare, within Pharmaceuticals &amp; Drugs. The same-industry benchmark covers 201 companies, which gives a useful frame for reading both valuation and profitability.<\/p>\n<p>On earnings valuation, the company\u2019s P\/E of 25.42 is below the industry median of 32.19 and well below the average of 49.13. Since the industry P\/E range runs from 3.39 to 668.68 across 169 companies with available data, Zydus does not look extreme on this measure.<\/p>\n<p>On book value, the P\/B ratio of 4.25 is above the industry median of 3.05 but slightly below the average of 4.44. Profitability is where the company compares more strongly. ROE of 19.69% is above both the median of 11.82% and the average of 11.12%, while ROCE of 21.39% is above the median of 13.71% and average of 13.62%. Its market capitalisation of Rs 1,15,211.69 crore is also far above the industry median of Rs 715.6 crore and higher than the industry average of Rs 14,150.82 crore.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,55,825.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,47,018.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,86,874.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,773<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,00,943.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">96.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Peer data places Zydus among the larger listed pharma names, with valuation that looks lower than several well-followed peers. Against Sun Pharmaceutical Industries, Zydus trades at a lower P\/E of 25.42 versus 37.31, while showing higher ROE and ROCE than Sun Pharma\u2019s 14.85% and 19.11%.<\/p>\n<p>Compared with Divi\u2019s Laboratories and Torrent Pharmaceuticals, the valuation gap is much wider. Both trade above 86 times earnings, while Zydus remains at 25.42 times. Divi\u2019s ROCE of 21.51% is only slightly above Zydus, while Torrent\u2019s ROE of 26.76% is stronger but its ROCE of 19.27% is lower.<\/p>\n<p>Against Cipla, the market capitalisations are close at Rs 1,15,211.69 crore for Zydus and Rs 1,12,773 crore for Cipla. Zydus also has a lower P\/E than Cipla\u2019s 33.17 and stronger ROE and ROCE than Cipla\u2019s 11.83% and 16%. Laurus Labs trades at a far higher P\/E of 96.14 and P\/B of 18.64 despite a smaller market capitalisation of Rs 1,00,943.83 crore. On the supplied peer set, Zydus screens as comparatively moderate on earnings valuation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Zydus_Lifesciences\"><\/span><strong>Why Investors Are Watching Zydus Lifesciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock fell 2.03% to Rs 1,126.7 and stayed close to the day\u2019s low of Rs 1,126.25.<\/li>\n<li>It moved from Rs 1,145.05 at the open to Rs 1,157.65 at the high before weakening through the session.<\/li>\n<li>The P\/E ratio of 25.42 is below the industry median of 32.19.<\/li>\n<li>ROE of 19.69% and ROCE of 21.39% are above the industry median and average.<\/li>\n<li>With a market cap of Rs 1,15,211.69 crore, it remains a major Healthcare stock within the listed pharma space.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Zydus_Lifesciences\"><\/span><strong>About Zydus Lifesciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus Lifesciences is part of the Healthcare sector and operates in the Pharmaceuticals &amp; Drugs industry. By market capitalisation, it is much larger than the industry median and also above the industry average, which helps explain why a one-day move in the stock can attract broad investor attention.<\/p>\n<p>Its peer set in the supplied data includes Sun Pharmaceutical Industries, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Cipla, and Laurus Labs. Relative to that group, the company combines scale with above-benchmark profitability and a lower earnings multiple than several prominent peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Zydus_Lifesciences_Share_Price_on_Univest\"><\/span><strong>Track Zydus Lifesciences Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use<a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences (ZYDUSLIFE) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Zydus Lifesciences Share Price can be tracked on Univest alongside valuation ratios, peer comparison, shareholding pattern, 52-week levels, and broader market context, helping readers assess whether a single-day decline changes the bigger picture.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Zydus_Lifesciences_Share_Price_falling_today\"><\/span><strong>Why is Zydus Lifesciences Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Zydus Lifesciences Share Price fell 2.03% to Rs 1,126.7 from the previous close of Rs 1,150. The supplied market data confirms the decline, but it does not establish a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Zydus_Lifesciences_Share_Price_Today\"><\/span><strong>What is Zydus Lifesciences Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock is at Rs 1,126.7, down Rs 23.3 or 2.03% in the session. The previous close was Rs 1,150. The intraday range extended from Rs 1,126.25 to Rs 1,157.65.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_valuation_and_profitability_metrics_show\"><\/span><strong>What do valuation and profitability metrics show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock trades at a P\/E of 25.42 and P\/B of 4.25, while ROE is 19.69% and ROCE is 21.39%. The relevant peer median P\/E is 32.19x. The peer average P\/E is 49.13x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_it_compare_with_industry_benchmarks\"><\/span><strong>How does it compare with industry benchmarks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Its P\/E is below the industry median of 32.19, while both ROE and ROCE are above the corresponding industry medians. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals &amp; Drugs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zydus Lifesciences Share Price falls to Rs 1,126.7. marking a 2.03% fall today. Market cap stands at Rs 1,15,211.69 crore.<\/p>\n","protected":false},"author":29,"featured_media":238421,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-238422","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["238421"],"rank_math_title":["Zydus Lifesciences Share Price Fall: Pharma Stock Analysis"],"rank_math_description":["Zydus Lifesciences Share Price fell 2.03% to Rs 1,126.7. Read today's price action, technical setup, fundamentals, sector metrics and peer analysis."],"rank_math_focus_keyword":["Zydus Lifesciences Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Zydus_Lifesciences_ZYDUSLIFE_Share_Price_Falls_203_Today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=238422"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238422\/revisions"}],"predecessor-version":[{"id":238423,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238422\/revisions\/238423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/238421"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=238422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=238422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=238422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}